Within the CD3+ T cell population, CD137-expressing T cells were found at a higher frequency in tumor cores with high CD137+ EBER+ NPC cells than in tumor cores with low CD137+ EBER+ NPC cells (Figure 1E). This evidence concerns the gene TNFRSF9 and neoplasm.